Objective-Ultrasound (US)-mediated destruction of contrast microbubbles causes capillary rupturing that stimulates arteriogenesis, whereas intramuscular implantation (im) of bone marrow mononuclear cells (BM-MNCs) induces angiogenesis. We therefore studied whether US-targeted microbubble destruction combined with transplantation of BM-MNCs can enhance blood flow restoration by stimulating both angiogenesis and arteriogenesis. Methods and Results-US-mediated destruction of phospholipid-coated microbubbles was applied onto ischemic hindlimb muscle and subsequently BM-MNCs were transfused. A significant enhancement in blood flow recovery after BubbleϩUSϩBM-MNC infusion (34% increase, PϽ0.05) was observed compared with BubbleϩUS (25%). The ratio of capillary/muscle fiber increased by BubbleϩUSϩBM-MNC-i.v (260%, PϽ0.01) than that in the BubbleϩUS group
T herapeutic angiogenesis, the ability to induce the formation of new blood vessels, is one of the most promising targets for regeneration therapy. To induce angiogenesis, investigators have delivered vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF/FGF2). or hypoxia-inducible factor-1␣/etoposide as recombinant proteins or genes. 1 Intramuscular injection of bone marrow mononuclear cells (BM-MNCs) was shown to be feasible in patients or animals with ischemic limbs by supplying angiogenic factors and endothelial progenitors. [2] [3] [4] A noninvasive cell delivery system that can target vascular endothelium would be a great advantage for manipulation of angiogenic cell therapy.
Ultrasound (US)-targeted microbubble destruction has been investigated as a new method for delivering drugs and genes to specific tissues. [5] [6] [7] [8] [9] [10] [11] This method involves the attach-ment of drugs or genes to gas-filled microbubbles, which are then circulated through the intravascular space and mechanically destroyed within the target organ. Theoretically, one can target any anatomic site that is accessible by US, including selected damaged regions. [5] [6] [7] [8] [9] [10] [11] Song et al have reported that US-targeted microbubble destruction causes capillary rupturing that stimulates arteriogenesis and an increase in blood flow in both normal 12 and ischemic 13 skeletal muscles, in which angiogenesis response is transient and unlikely contributes to chronic restoration of blood flow. We previously demonstrated that the recruitment of BM-MNCs and platelets stimulates angiogenesis response in ischemic muscles by releasing potent angiogenic factors, such as VEGF or bFGF, and supply of endothelial progenitors. 3, 14 Furthermore, we have recently reported that systemically transplanted BM-MNCs can be firmly attached onto the injured vascular endothelium in an adhesive molecule-dependent manner. 15 We therefore examined whether UStargeted microbubble destruction combined with intravenous transplantation of BM-MNCs causes angiogenesis response as well as arteriogenesis in a rat model with an ischemic hindlimb, leading to an enhancement of chronic blood flow restoration. Interestingly, we found that platelet-derived factors activated by US-targeted microbubble destruction induce the expression of adhesive molecules on the endothelium and subsequent attachment of transplanted BM-MNCs, resulting in an enhancement of formation of neocapillaries and new arterioles and an increase in regional blood flow recovery.
Materials and Methods

Microbubble Preparations
BR14 (Bracco Diagnostics) is a new ultrasound contrast agent, consisting of perfluorocarbon-containing microbubbles stabilized by a phospholipid monolayer. 16, 17 The suspension of gas microbubbles is reconstituted immediately before use by injecting 5 mL of 0.9% sodium chloride. The mean diameter of bubbles is 2.3 to 2.5 m and the bubble concentration is Ϸ6ϫ10 8 per ml. BR14 was administered as a 1 mL bolus injection via contralateral femoral vein.
Isolation of BM-MNC and Characterization of Endothelial-Lineage Cells
BM-MNCs were isolated from SEA/LEW rat femoral bone and centrifuged by density gradient (Lymphoprep; Nycomed). The MNC fraction was labeled with red-fluorescence cell linker (PKH26-GL; Sigma). 2, 3, 14 Endothelial lineage cells were analyzed by fluorescence-activated cell sorter (FACS) using DiI-acetylated LDL (acLDL) incorporation (Biogenesis) and Ulex lectin binding (Sigma) as described previously. 2, 3, 14 
Hindlimb Ischemia, US Application, and Transfusion of BM-MNCs
Unilateral hindlimb ischemia was induced by resecting the left femoral artery as described. 2, 18 Arteriogenesis that restores the regional blood flow was reported to be observed 3 days after induction of limb ischemia of rats. 12, 13 We therefore performed the infusion of microbubble at day 3 after limb ischemia to efficiently deliver microbubble BR14 to the ischemic site. We divided the rats into the following five groups: (1) Control (saline injection, nϭ8); (2) Bubble (1 mL BR14)ϩUS (nϭ8); (3) BubbleϩUSϩBM-MNCi.v. (nϭ8), BM-MNC (2ϫ10 7 in 1 mL saline) injected from contralateral femoral vein 1 minute after BubbleϩUS; (4) BM-MNCi.m. (nϭ8), BM-MNC (2ϫ10 7 ) intramuscularly implanted into the ischemic limb; and (5) BM-MNC-i.v. (nϭ8); BM-MNC (2ϫ10 7 in 1 mL saline). BM-MNC (2ϫ10 7 ) included 0.3Ϯ0.04ϫ10 7 platelets.
The skin overlying the ischemic thigh muscle to be treated was reflected back, ultrasound gel was placed over the ischemic muscle, and 1-MHz transducer (S-probe, Effective Radiating Area: 0.9 cm 2 ; Ito Co Ltd) was held 3 mm over the muscle and to keep the skin temperature around Ϸ37°C. A continuous sinusoidal wave ultrasound (1MHz, 2W/cm 2 , Beam Nonuniformity Ratio: 3.6; ITO-US-700) was applied for 1 minute immediately after microbubble injection. To clarify whether the microbubbles really reach ischemic tissues after infusion from contralateral femoral vein, the delivery of injected microbubbles to the ischemic area was examined by a diagnostic ultrasound echography (Sonos-5500) equipped with an ultraband S12 sector transducer.
Evaluation of Neocapillary and Immunohistochemical Analysis
Four pieces of ischemic tissues from the adductor and semimembranous muscles were obtained 28 days after limb ischemia. Frozen sections were stained with antibodies for smooth muscle (SM) ␣-actin (Sigma) and anti-factor VIII (DAKO) antibodies. The appropriate secondary antibodies conjugated with fluorescein isothiocyanate (FITC) or rhodamine were used. Ten fields from 2 muscle samples of each animal were randomly selected for the vessel count. To ensure that vessel densities were not overestimated as a consequence of myocyte atrophy or underestimated because of interstitial edema, the capillary/muscle fiber ratio was determined. 3, 18 
Electron Microscope
Femoral arteries in skeletal muscles on which targeted US was applied were isolated after BubbleϩUS treatment (nϭ4), fixed by 2.5% glutaraldehyde and 1.5% osmium acid, dried, and viewed by electron microscope (HITATI S-700). 15
Cell Culture and Platelet-Rich Plasma Isolation
Human umbilical vein endothelial cells (HUVECs; Kurabo) were cultured in HuMedia-EG2 medium. For use in the study apparatus, HUVECs (2nd or 3rd passages) were plated on 22-mm fibronectincoated cover slips. 15 Peripheral blood was drawn from healthy volunteers and mixed with 0.1 volume of citrate (108 mmol/L). Whole blood was centrifuged at 150g for 10 minutes to harvest platelet-rich plasma (PRP).
Adhesion Assay Under Laminar Flow and Immunofluorescence Study
HUVECs were incubated for 30 minutes with serum-free medium with or without freshly prepared 10% platelet-rich plasma, and then stimulated by (1) 10% BubbleϩUS (1MHz, 1.5W, 30 seconds) in 10% PRP (BubbleϩUS with platelet group), (2) 10% BubbleϩUS in PRP (BubbleϩUS without platelet), (3) incubation media (in which 10% platelet-rich medium was stimulated by 10% BubbleϩUS), or (4) US with platelet (in which 10% platelet-rich medium was stimulated by US alone), nϭ6 in each experiment. HUVECs were placed on the cold plate to prevent the heating by the US, and adhesion assay under laminar flow was performed as previously described. 15 For further detail, please see the supplemental Methods, available online at http://atvb.ahajournals.org. Stimulated HUVECs were fixed by 4% paraformaldehyde 1 hour after stimulation and incubated with anti-P-selectin (R&D Systems, Inc) and anti-platelet glycoprotein (GP)-Ib antibody (DAKO). The appropriate secondary antibodies conjugated with FITC or rhodamine were used. Nuclei were stained with 4Ј,6Ј-diamidino-2phenylindole dihydrochloride (DAPI) and viewed by a fluorescence microscope (Olympus OX71).
Laser Doppler Perfusion Image and Angiography
Laser doppler perfusion image (LDPI) and angiography were performed as previously described 3, 18 For further detail, please see the supplemental Methods.
Statistical Analysis
Statistical analyses were performed with 1-way ANOVA followed by pair-wise contrasts using the Dunnett test. Data (meanϮSE) were considered statistically significant when PϽ0.05.
Results
Incidence of Endothelial-Lineage Cells in BM-MNCs
FACS analysis indicated that 28Ϯ1.8% and 31Ϯ1.5% of BM-MNCs incorporated DiI-acLDL and bound Ulex-lectin (nϭ5), respectively, and 20Ϯ1.2% of cells were positive for both markers. Endothelial-lineage cells were considered to be included in this fraction as reported. 2,3,14
Laser Doppler Blood Perfusion
Subcutaneous blood perfusion was analyzed by LDPI imaging (Figure 1 ). Intravenous injection of BM-MNCs (BM-MNC-i.v.) did not cause a significant increase in the blood flow recover compared with the control (saline injection; Figure 1 ). Treatment with BubbleϩUS without BM-MNCs-i.v. showed a moderate increase (25Ϯ2% at Day 28 versus control, PϽ0.05), whereas the combination of BubbleϩUS and BM-MNCs-i.v. induced a further increase (34Ϯ2% versus control at Day 28, PϽ0.01), which was significantly higher than that of BubbleϩUS manipulation alone (PϽ0.05). The blood perfusion recovery by BubbleϩUSϩBM-MNC-i.v. was comparable to blood perfusion by BM-MNC-i.m. (38Ϯ3%). Blood perfusion after USϩBM-MNC-i.v. without Bubble did not significantly differ from those in BM-MNC-i.v. alone or control groups (3Ϯ1% versus control at Day 28, nϭ8; data not shown), suggesting that the combination of BM-MNCs infusion with BubbleϩUS significantly improves the blood flow recovery after limb ischemia compared with each manipulation alone, and that the efficient cell delivery system depends on USmediated destruction of microbubbles.
Neocapillary and Arteriole Formation
Formation of capillaries and arterioles was evaluated by factor VIII-positive and SM ␣-actin-positive vessels. The ratio of capillary/muscle fiber (factor VIII-positive and SM ␣-actin-negative vessel) was significantly increased in the BubbleϩUSϩBM-MNC-i.v. group (260Ϯ15% versus control, PϽ0.01), which was greater (PϽ0.01) than that of BubbleϩUS group (172Ϯ11% versus control, PϽ0.05). The ratio of arteriole/muscle fiber (factor VIII-positive and SM ␣-actin-positive vessel) was also increased by BubbleϩUSϩBM-MNC-i.v. (188Ϯ10% versus control, PϽ0.01), which was greater (PϽ0.05) than that in the BubbleϩUS group (146Ϯ9% versus control, PϽ0.05; Figure  2A ). Transfused BM-MNCs (labeled with red fluorescence) were found to be incorporated into microvessels by BubbleϩUSϩBM-MNC-i.v. (arrows in Figure 2B ). These findings suggest that BubbleϩUSϩBM-MNC-i.v. enhances both angiogenesis as well as arteriogenesis response.
To examine the specificity of this cell delivery system, we examined the distribution of transfused BM-MNCs in other tissues (kidney, spleen, liver, heart, pancreas, small intestines, and brain) 3 weeks after targeted cell delivery by BubbleϩUSϩBM-MNCs-iv. Small numbers of labeled BM-MNCs were detected in the kidney (mainly in the tubule) and greater numbers of BM-MNCs were observed in the spleen, whereas no labeled cells were detected in other tissues (Figure I, available online at http://atvb.ahajournals.org).
Arteriogenesis Response Evaluated by Angiography
Compared with angiogenesis formed by capillary sprouting, arteriogenesis is often studied with the use of angiography. On the postoperative day 28, all animals were subjected to iliac angiography. Representative angiograms (nϭ4 in each group) are shown in Figure II (available online at http:// atvb.ahajournals.org), in which arrows indicate the ligated ends of femoral arteries. Collateral vessels in the thigh area were quantitatively counted using 5-mm 2 grids. 3, 18 An apparent increase in collateral vessel formation was observed in the BubbleϩUSϩBM-MNC-i.v. and BM-MNC-i.m. (4.2Ϯ0.2fold and 4.3Ϯ0.2-fold, nϭ6, respectively; PϽ0.001) compared with that in the BM-MNC-i.v. group. The increase in the BubbleϩUS group was 1.8Ϯ0.1-fold (PϽ0.05) when compared with that in the BM-MNC-i.v. group, which was significantly smaller (PϽ0.01) than that of the BubbleϩUSϩBM-MNC-i.v. group. There was no significant difference between control (saline infusion) and BM-MNCi.v. groups.
Delivery of Microbubbles to the Ischemic Muscle
Arteriogenesis that restores the regional blood flow was observed 3 days after induction of limb ischemia of rats. 12, 13 We therefore performed the infusion of microbubble at day 3 after limb ischemia to efficiently deliver microbubble BR14 to the ischemic site. We further examined whether the transfused microbubbles really reach the hindlimb muscle at 3 days after induction of ischemia. Apparent increase in the contrast densities in the ischemic thigh muscle (indicated by arrows in Figure III , available online at http://atvb. ahajournals.org) was observed Ϸ15 seconds after injection of microbubbles in both control (normal) and ischemic limbs compared with the pre-images before injection of microbubbles. The increase in contrast shadow diminished after 1 minute of US stimulation, indicating that microbubbles really reach ischemic hindlimb muscles after venous infusion.
Electromicroscopy
A previous study reported the presence of small holes in the endothelial cells treated with BubbleϩUS, 11 whereas we could not detect the presence of apparent small holes in the vascular endothelium in the skeletal muscle on which the BubbleϩUS was applied. Neither adhesion of MNCs nor formation of fibrin network including platelets was detected on the surface of normal endothelium or endothelium stimulated by US without microbubbles. Interestingly, we found the attachment of platelets associated with fibrin network and MNCs on the surface of endothelium in all arteries treated by BubbleϩUSϩBM-MNCs infusion (nϭ6; Figure 3 ), whereas no adhesion of platelets or MNCs was detected in the USϩBM-MNC group without microbubbles (nϭ6; data not shown).
Induction of Adhesion Molecules
We have reported that transplanted BM-MNCs can firmly attach onto the injured vascular endothelium in an adhesive molecule-dependent manner. 15 We therefore examined the expression profile of adhesive molecules on HUVECs treated by BubbleϩUS. The expression of adhesive molecules (Pselectin or ICAM-1) was not induced when HUVECs were stimulated by BubbleϩUS in the medium without platelets. Because we found that adhesion of the fibrin network including platelets was consistently observed on the surface of endothelium in all BubbleϩUS-treated samples (Figure 3 ), we next examined the involvement of platelet-derived factors in the adhesion of BM-MNCs. Interestingly, the expression of P-selectin (red fluorescence, right panel in Figure 4 ) and ICAM-1 was markedly induced in both HUVECs and attaching glycoprotein Ib-positive platelets (merged, yellow), when HUVECs were stimulated by BubbleϩUS in the medium including platelets (only P-selectin data shown in Figure 4 ).
We also studied whether factors released from the platelets stimulated by BubbleϩUS are involved in the induction of adhesion molecules. Therefore, we examined the effect of the incubation medium, in which platelet-including medium was stimulated by BubbleϩUS, on the induction of adhesion molecules. The addition of incubation medium caused the apparent increase in P-selectin expression on HUVECs (red fluorescence, right panel in Figure 4 ), suggesting that the factors released from the platelets stimulated by BubbleϩUS are closely involved in the induction of adhesion molecules on HUVECs. Treatment of HUVECs by US alone without microbubbles in the medium including platelets did not induce any expression of adhesive molecules (data not shown). These findings suggest that activation of platelets by BubbleϩUS and release of platelet-derived proinflammatory factors play a key role in the induction of adhesion molecules in the endothelial cells.
Laminar Flow Assay
We next studied whether the adhesive activity of BM-MNCs on the endothelium was actually modulated by BubbleϩUS-activated platelets under laminar flow condition. HUVECs were stimulated by BubbleϩUS in the medium containing platelets and then the adhesion ratio of BM-MNCs on HUVECs was evaluated under laminar flow as previously reported. 15 The presence of platelets in the medium markedly increased the adhesion ratio of BM-MNCs (3.5-fold, PϽ0.01) compared with BubbleϩUS without platelets ( Figure 5 ). Moderate increase (1.9-fold, PϽ0.01) was observed in the incubation medium group (in which medium including platelets was stimulated by BubbleϩUS and then added to HUVECs) compared with the ratio in the untreated HUVECs (control). Treatment of HUVECs by US stimulation without microbubbles in the medium including platelets or addition of control medium including platelet alone (without US stimulation) did not cause a significant increase in the adhesion ratio of BM-MNCs compared with the ratio in the untreated HUVEC (data not shown).
Discussion
Angiogenic cell therapy by intramuscular implantation of autologous BM-MNCs was shown to be feasible in patients with ischemic limbs. 2 Because intramuscular implantation is The presence of platelets and expression of P-selectin are shown by immunostaining with anti-GP-Ib (green fluorescence) and anti-P-selectin (red fluorescence) antibodies and DAPI staining (blue fluorescence). The expression of P-selectin and adhesion of platelets were observed on HUVECs, when HUVECs were stimulated by BubbleϩUS in the medium containing 10% platelets or exposed to the incubation medium (in which 10% platelet-including medium was stimulated by BubbleϩUS). The expression of P-selectin (red fluorescence) on HUVECs and attaching platelets was markedly induced. Barϭ50 m.
invasive at the injected sites, the development of a noninvasive cell delivery system that can target vascular endothelium would be a great advantage for the manipulation of angiogenic cell therapy. A new delivery system of drugs or genes has been developed using US-targeted microbubble destruction; the drugs or genes that attach onto gas-filled microbubbles circulate through the intravascular space and are mechanically destroyed within the target organ by ultrasound, [5] [6] [7] [8] [9] [10] [11] whereas no studies were reported to determine whether this method is feasible for delivering the "cells" to specific vascular sites.
US-targeted microbubble destruction was reported to cause an inflammatory action on the cell surface by making small holes that revert to a normal appearance within 24 hours. 10, 11 Song et al have reported that US-targeted microbubble destruction causes capillary rupturing that stimulates arteriogenesis and an increase in blood flow in both normal 12 and ischemic 13 skeletal muscles, in which angiogenesis response is transient and unlikely contributes to chronic restoration of blood flow. They concluded that arteriogenesis response rather than angiogenesis plays a major role in USϩmicrobubble-stimulated blood flow recovery. We previously demonstrated that the recruitment of BM-MNCs and platelets stimulates angiogenesis response in the ischemic muscles by releasing potent angiogenic factors, such as VEGF or bFGF, and supply of endothelial progenitors. 3, 14 Furthermore, we have recently reported that systemically transplanted BM-MNCs can be firmly attached onto the injured vascular endothelium in an adhesive molecule-dependent manner. 15 We therefore expanded the previous studies by Song et al 12, 13 and examined whether US-targeted microbubble destruction combined with intravenous transplantation of BM-MNCs causes both angiogenesis and arteriogenesis response in an ischemic hindlimb model, leading to a greater enhancement of blood flow restoration.
We found that (1) intravenous infusion of BM-MNCs combined with US-mediated destruction of microbubbles markedly enhances the restoration of regional blood perfusion in ischemic hindlimbs by stimulating both chronic angiogenesis and arteriogenesis response, and (2) release of platelet-derived proinflammatory factors activated by USmediated destruction of microbubbles causes the adhesion of transfused BM-MNCs on endothelium by inducing the expression of adhesion molecules (P-selectin and ICAM-1). We found that BM-MNCs transfused intravenously were trapped by the spleen and a few BM-MNCs were present in the renal tubules. Considering that BM-derived hematopoietic stem cells were reported to transdifferentiate to renal tubular cells and improve renal function in the ischemia-reperfusion injury model, 19 the present study establishes for the first time that targeted delivery of BM-MNCs by US destruction of microbubbles is an efficient cell delivery system for therapeutic angiogenesis and arteriogenesis, and that the presence of platelets and/or platelet-derived proinflammatory factors activated by USϩmicrobubbles play an important role in the targeted adhesion of BM-MNCs on vascular endothelium.
Previous studies have indicated that platelet attachment to an inter-or sub-endothelial matrix of endothelial cells promotes selectin-mediated leukocyte adhesion to the damaged endothelium under the flow assay condition. 20, 21 Inhibition of P-selectin caused a marked inhibition of leukocyte adhesion at a high shear stress. 20 P-selectin is a receptor for leukocytes and monocytes when its expression is induced on activated platelets and endothelium. This property facilitates rapid adhesion of leukocytes to endothelium in injury tissue regions and enhances plateletleukocyte interactions at sites of inflammation. Endothelial P-selectin is located on membranes of Weibel-Plade bodies, the secretory granules of endothelium in which large multimers of von Willebrand factor (vWF) are stored. 22 After cellular stimulation with agonists such as thrombin or histamine, P-selectin is rapidly expressed on the endothelial cell surface, making it an excellent candidate for directing adherence of unstimulated leukocytes toward endothelium within minutes of tissue injury. 23 Furthermore, we have reported that BM-MNCs have a higher rolling and adhesive activities because of the greater expressions of adhesive molecules such as P-selectin compared with peripheral blood-derived leukocytes. 15 In this study, we found that factors released from platelets stimulated by microbubble destruction are responsible for the attachment of platelets and BM-MNCs onto the endothelium and the induction of endothelial P-selectin and ICAM-1. The present data from the flow assay also confirm that platelet-derived factors play a key role for adhesion of BM-MNCs onto the endothelial cells under laminar flow. Although we previously showed that plateletderived VEGF is mainly associated with the angiogenesis response by platelet implantation, 3 preincubation with antibodies for VEGF, bFGF, or PDGF-BB showed no influence on the induction of endothelial P-selectin and ICAM-1 (unpublished observation). Further studies will be required to identify the platelet-derived proinflammatory cytokines responsible for induction of endothelial adhesion molecules. Taken together, these findings suggest that release of platelet-derived proinflammatory factors and direct interaction of platelet onto the endothelial matrix, initiated by US-microbubble destruction, is an underlying mechanism for adhesion of the transfused BM-MNCs on the endothelium under shear stress.
The previous studies showed that US-mediated destruction of microbubbles induces arteriogenesis response in the skeletal muscle, whereas angiogenesis response is transient and unlikely contributes to the increase in the regional blood flow. 12 The arteriogenesis response consists of the formation of new arterioles, which presumably occurs when preexisting capillaries acquire SM coating, and an increase in the diameter of these newly formed and/or preexisting arterioles into channels with larger diameters. 13 Compared with angiogenesis formed by capillary sprouting, arteriogenesis is often studied with the use of conventional angiography. Our angiography finding is consistent with the arteriogenesis response, and the immunohistological data suggest the angiogenesis and arteriogenesis response as evaluated by the increases in capillary numbers and SM coated arterioles, respectively. The neocapillary formation was observed in the day 28 samples, suggesting that the angiogenesis is a chronic response in our study. The controversy with the studies by Song et al 12, 13 may be attributable to the difference in the used microbubbles (albumin-coated Optison versus phospholipids-coated BR14). Recruitment of monocytes triggered by monocyte chemoattractant protein-1 was shown to induce arteriogenesis in inflammatory ischemic sites. 24 Because BM-MNCs contain monocyte-lineage progenitor cells, 15 it is plausible that recruitment of BM-MNCs contributes to arteriogenesis together with inflammation response by USϩmicrobubble-mediated capillary rupturing.
In conclusion, the present study demonstrates that intravenous transfusion of BM-MNCs combined with US-destruction of microbubbles is an efficient targeted cell delivery system for therapeutic angiogenesis as well as arteriogenesis, in which the release of platelet-derived proinflammatory factors activated by BubbleϩUS plays a key role in the attachment of transplanted BM-MNCs onto the endothelial layer.
